Dr. Mark Rasenick presented a symposium on confluence and contrast between the antidepressant properties ketamine and psychedelics
- Released On:July 07, 2023
- Credits:
- International Society for Serotonin Research
Dr. Mark Rasenick presented a symposium on confluence and contrast between the antidepressant properties ketamine and psychedelics: A mechanistic view at the International Society for Serotonin Research in Cancun. He also presented a symposium at the CINP (International Neuropsychopharmacology Congress) in Montreal entitled: A simple protein biomarker for depression and antidepressant action is elicited by SSRIs, Ketamine and Several Psychedelic Compounds.
Read more at: International Society for Serotonin Research
Featured Profile
Mark Rasenick PhD
- Distinguished Professor of Physiology & Biophysics and Psychiatry
- Director, Biomedical Neuroscience Training Program
- Research Career Scientist, Jesse Brown VAMC
- University of Illinois Chicago College of Medicine
- Distinguished Professor of Physiology & Biophysics and Psychiatry
- Director, Biomedical Neuroscience Training Program
- Research Career Scientist, Jesse Brown VAMC
- University of Illinois Chicago College of Medicine
312-996-6641
raz
uic [dot] edu